Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-EN Version v4-FR
Language English French
Date Updated 2019-01-04 2018-08-17
Drug Identification Number 00463221 00463221
Brand name LYSODREN LYSODREN
Common or Proper name Mitotane Mitotane
Company Name LABORATOIRE HRA PHARMA LABORATOIRE HRA PHARMA
Ingredients MITOTANE MITOTANE
Strength(s) 500MG 500MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 1 BTL x 100 1 BTL x 100
ATC code L01XX L01XX
ATC description OTHER ANTINEOPLASTIC AGENTS OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2018-12-28 2018-10-31
Actual start date
Estimated end date 2018-12-28 2018-11-01
Actual end date 2019-01-02
Shortage status Resolved Anticipated shortage
Company comments Orders are being allocated. Orders are being allocated.
Health Canada comments